Global Factor VIII Deficiency Treatment Market Insights and Forecast to 2028

Global Factor VIII Deficiency Treatment Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hemophilia A Drugs
1.2.3 Hemophilia A Inhibitors Treatment
1.2.4 Von Willebrand Disease Treatment
1.3 Market by Application
1.3.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Factor VIII Deficiency Treatment Market Perspective (2017-2028)
2.2 Factor VIII Deficiency Treatment Growth Trends by Region
2.2.1 Factor VIII Deficiency Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Factor VIII Deficiency Treatment Historic Market Size by Region (2017-2022)
2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Region (2023-2028)
2.3 Factor VIII Deficiency Treatment Market Dynamics
2.3.1 Factor VIII Deficiency Treatment Industry Trends
2.3.2 Factor VIII Deficiency Treatment Market Drivers
2.3.3 Factor VIII Deficiency Treatment Market Challenges
2.3.4 Factor VIII Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue
3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2017-2022)
3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue
3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2021
3.5 Factor VIII Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Factor VIII Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Factor VIII Deficiency Treatment Breakdown Data by Type
4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2017-2022)
4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2023-2028)
5 Factor VIII Deficiency Treatment Breakdown Data by Application
5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2017-2022)
5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Factor VIII Deficiency Treatment Market Size (2017-2028)
6.2 North America Factor VIII Deficiency Treatment Market Size by Type
6.2.1 North America Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
6.2.2 North America Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
6.2.3 North America Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
6.3 North America Factor VIII Deficiency Treatment Market Size by Application
6.3.1 North America Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
6.3.2 North America Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
6.3.3 North America Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
6.4 North America Factor VIII Deficiency Treatment Market Size by Country
6.4.1 North America Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
6.4.2 North America Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Factor VIII Deficiency Treatment Market Size (2017-2028)
7.2 Europe Factor VIII Deficiency Treatment Market Size by Type
7.2.1 Europe Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
7.2.2 Europe Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
7.2.3 Europe Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
7.3 Europe Factor VIII Deficiency Treatment Market Size by Application
7.3.1 Europe Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
7.3.2 Europe Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
7.3.3 Europe Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
7.4 Europe Factor VIII Deficiency Treatment Market Size by Country
7.4.1 Europe Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
7.4.2 Europe Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2017-2028)
8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Factor VIII Deficiency Treatment Market Size (2017-2028)
9.2 Latin America Factor VIII Deficiency Treatment Market Size by Type
9.2.1 Latin America Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
9.3 Latin America Factor VIII Deficiency Treatment Market Size by Application
9.3.1 Latin America Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
9.4 Latin America Factor VIII Deficiency Treatment Market Size by Country
9.4.1 Latin America Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2017-2028)
10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor VIII Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.2.5 Takeda Recent Developments
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Company Details
11.3.2 Bayer HealthCare Business Overview
11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.3.5 Bayer HealthCare Recent Developments
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Factor VIII Deficiency Treatment Introduction
11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.4.5 CSL Recent Developments
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Factor VIII Deficiency Treatment Introduction
11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.5.5 Grifols Recent Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.6.5 Novo Nordisk Recent Developments
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.7.5 F. Hoffmann-La Roche Recent Developments
11.8 Kedrion
11.8.1 Kedrion Company Details
11.8.2 Kedrion Business Overview
11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.8.5 Kedrion Recent Developments
11.9 Octapharma
11.9.1 Octapharma Company Details
11.9.2 Octapharma Business Overview
11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.9.5 Octapharma Recent Developments
11.10 Biogen Idec
11.10.1 Biogen Idec Company Details
11.10.2 Biogen Idec Business Overview
11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.10.5 Biogen Idec Recent Developments
11.11 BioMarin Pharmaceutical
11.11.1 BioMarin Pharmaceutical Company Details
11.11.2 BioMarin Pharmaceutical Business Overview
11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.11.5 BioMarin Pharmaceutical Recent Developments
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Details
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.12.5 Sangamo Therapeutics Recent Developments
11.13 Spark Therapeutics
11.13.1 Spark Therapeutics Company Details
11.13.2 Spark Therapeutics Business Overview
11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.13.5 Spark Therapeutics Recent Developments
11.14 Swedish Orphan Biovitrum
11.14.1 Swedish Orphan Biovitrum Company Details
11.14.2 Swedish Orphan Biovitrum Business Overview
11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.14.5 Swedish Orphan Biovitrum Recent Developments
11.15 Uniqure NV
11.15.1 Uniqure NV Company Details
11.15.2 Uniqure NV Business Overview
11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.15.5 Uniqure NV Recent Developments
11.16 Amarna Therapeutics
11.16.1 Amarna Therapeutics Company Details
11.16.2 Amarna Therapeutics Business Overview
11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.16.5 Amarna Therapeutics Recent Developments
11.17 Dimension Therapeutics
11.17.1 Dimension Therapeutics Company Details
11.17.2 Dimension Therapeutics Business Overview
11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
11.17.5 Dimension Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Hemophilia A Drugs
Table 3. Key Players of Hemophilia A Inhibitors Treatment
Table 4. Key Players of Von Willebrand Disease Treatment
Table 5. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Factor VIII Deficiency Treatment Market Share by Region (2017-2022)
Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Factor VIII Deficiency Treatment Market Share by Region (2023-2028)
Table 11. Factor VIII Deficiency Treatment Market Trends
Table 12. Factor VIII Deficiency Treatment Market Drivers
Table 13. Factor VIII Deficiency Treatment Market Challenges
Table 14. Factor VIII Deficiency Treatment Market Restraints
Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Factor VIII Deficiency Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Factor VIII Deficiency Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021)
Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service
Table 22. Date of Enter into Factor VIII Deficiency Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Factor VIII Deficiency Treatment Revenue Share by Application (2017-2022)
Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Factor VIII Deficiency Treatment Revenue Share by Application (2023-2028)
Table 32. North America Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Factor VIII Deficiency Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Factor VIII Deficiency Treatment Product
Table 65. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Takeda Company Details
Table 68. Takeda Business Overview
Table 69. Takeda Factor VIII Deficiency Treatment Product
Table 70. Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 71. Takeda Recent Developments
Table 72. Bayer HealthCare Company Details
Table 73. Bayer HealthCare Business Overview
Table 74. Bayer HealthCare Factor VIII Deficiency Treatment Product
Table 75. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 76. Bayer HealthCare Recent Developments
Table 77. CSL Company Details
Table 78. CSL Business Overview
Table 79. CSL Factor VIII Deficiency Treatment Product
Table 80. CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 81. CSL Recent Developments
Table 82. Grifols Company Details
Table 83. Grifols Business Overview
Table 84. Grifols Factor VIII Deficiency Treatment Product
Table 85. Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 86. Grifols Recent Developments
Table 87. Novo Nordisk Company Details
Table 88. Novo Nordisk Business Overview
Table 89. Novo Nordisk Factor VIII Deficiency Treatment Product
Table 90. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 91. Novo Nordisk Recent Developments
Table 92. F. Hoffmann-La Roche Company Details
Table 93. F. Hoffmann-La Roche Business Overview
Table 94. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product
Table 95. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 96. F. Hoffmann-La Roche Recent Developments
Table 97. Kedrion Company Details
Table 98. Kedrion Business Overview
Table 99. Kedrion Factor VIII Deficiency Treatment Product
Table 100. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 101. Kedrion Recent Developments
Table 102. Octapharma Company Details
Table 103. Octapharma Business Overview
Table 104. Octapharma Factor VIII Deficiency Treatment Product
Table 105. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 106. Octapharma Recent Developments
Table 107. Biogen Idec Company Details
Table 108. Biogen Idec Business Overview
Table 109. Biogen Idec Factor VIII Deficiency Treatment Product
Table 110. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 111. Biogen Idec Recent Developments
Table 112. BioMarin Pharmaceutical Company Details
Table 113. BioMarin Pharmaceutical Business Overview
Table 114. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product
Table 115. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 116. BioMarin Pharmaceutical Recent Developments
Table 117. Sangamo Therapeutics Company Details
Table 118. Sangamo Therapeutics Business Overview
Table 119. Sangamo Therapeutics Factor VIII Deficiency Treatment Product
Table 120. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 121. Sangamo Therapeutics Recent Developments
Table 122. Spark Therapeutics Company Details
Table 123. Spark Therapeutics Business Overview
Table 124. Spark Therapeutics Factor VIII Deficiency Treatment Product
Table 125. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 126. Spark Therapeutics Recent Developments
Table 127. Swedish Orphan Biovitrum Company Details
Table 128. Swedish Orphan Biovitrum Business Overview
Table 129. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product
Table 130. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 131. Swedish Orphan Biovitrum Recent Developments
Table 132. Uniqure NV Company Details
Table 133. Uniqure NV Business Overview
Table 134. Uniqure NV Factor VIII Deficiency Treatment Product
Table 135. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 136. Uniqure NV Recent Developments
Table 137. Amarna Therapeutics Company Details
Table 138. Amarna Therapeutics Business Overview
Table 139. Amarna Therapeutics Factor VIII Deficiency Treatment Product
Table 140. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 141. Amarna Therapeutics Recent Developments
Table 142. Dimension Therapeutics Company Details
Table 143. Dimension Therapeutics Business Overview
Table 144. Dimension Therapeutics Factor VIII Deficiency Treatment Product
Table 145. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 146. Dimension Therapeutics Recent Developments
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor VIII Deficiency Treatment Market Share by Type: 2021 VS 2028
Figure 2. Hemophilia A Drugs Features
Figure 3. Hemophilia A Inhibitors Treatment Features
Figure 4. Von Willebrand Disease Treatment Features
Figure 5. Global Factor VIII Deficiency Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Factor VIII Deficiency Treatment Report Years Considered
Figure 10. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Factor VIII Deficiency Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Factor VIII Deficiency Treatment Market Share by Players in 2021
Figure 14. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2021
Figure 16. North America Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Factor VIII Deficiency Treatment Market Size Share by Region (2017-2028)
Figure 36. China Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
Figure 56. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Busi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs